Urinary tract infections (UTIs) are clinically important problems that lead to serious morbidity and mortality, and indwelling urinary catheters are a major factor of UTIs. In this study, we applied clustered regularly interspaced short palindromic repeats (CRISPR) genome editing to generate DluxS mutant strains from clinical isolates of Escherichia coli SE15, which is one of major pathogens and can cause colonization and biofilm formation in the catheter. A major regulatory pathway of such biofilm formation on medical devices is the quorum sensing mechanism via small molecule autoinducer-2 synthesized by LuxS enzyme. Here, we used the CRISPR-Cas9 system for precise deletion of luxS gene in clinical isolate E. coli SE15. To this end, we constructed a donor DNA for homologous recombination to delete 93 bases in the chromosomal target (luxS) and observed the success rate of luxS deletion to be 22.7 %. We conducted biofilm assay to observe decreased biofilm formation in the E. coil SE15 DluxS mutants compared to wild-type E. coil SE15. Quantitative real-time PCR analysis of E. coil SE15 DluxS mutants showed that the expression of luxS was below detection level. We also observed that the relative mRNA levels of biofilm-formation-related genes, such as mqsR, pgaBC and csgEF, were significantly decreased in E. coil SE15 DluxS mutants compared to wild-type. We conclude that genome editing by CRISPR-Cas9 system is an effective tool to dissect the molecular mechanism of biofilm formation in medically important strains, and the study may serve as a basis for developing novel medical intervention against UTIs caused by biofilm.
INTRODUCTION
Urinary tract infections (UTIs) are the most common nosocomial infection, accounting for over 40 % of all hospitalassociated infections, and can cause serious morbidity and mortality. An estimated 80 % of all nosocomial UTIs are catheter-associated urinary tract infections (CA-UTIs) related to use of an indwelling urinary catheter [1] . The pathogenesis of CA-UTIs involves bacterial biofilm formation on the inner surfaces of an indwelling urinary catheter [2, 3] .
In the previous studies, Escherichia coli was reported to be the causative pathogen in 70-95 % of UTIs and was isolated from the urine of 20-50 % of patients with indwelling urinary catheters [4, 5] . Such E. coli strains, named uropathogenic E. coli strains, are able to colonize and form biofilm in urinary tracts and artificial conditions such as catheter. The biofilm formation by E. coli on the surface of the catheter can trigger CA-UTIs, one of the most common nosocomial infections [6, 7] . Such biofilm formation is mainly regulated by a cell-to-cell communication called quorum sensing (QS). Upon activation of QS mechanism, bacteria secrete autoinducers (AIs) to the extracellular environment, and once a high cell density is reached, they upregulate biofilm formation and development [8] . The QS system in E. coli has been an issue of major interest, and several intra-extracellular signalling systems, such as LuxR homology SdiA, LuxS/AI-2 system, AI-3 and indole, have been reported [2, [9] [10] [11] . Notably, among the QS systems, the LuxS/AI-2 system is uniquely linked to central metabolism and AI-2 directly stimulates biofilm in E. coli [12, 13] .
Several technologies for targeted gene editing such as homologous recombination, allelic replacement, integrases and directed nucleases have been available in eukaryotes and prokaryotes [14] . In bacterial cells, mutagenesis of a gene generally required introduction of a selection marker in the edited site or needed a two-step process that included a counter-selection system for homologous recombination [15, 16] . In addition, phage recombination proteins have been applied for genome editing to improve homologous recombination by linear DNA or oligonucleotides [17] . However, since this method lacks a mutant selection step, the efficiency can be relatively low for mutant construction. Therefore, many colonies had to be analysed to find a genetically engineered colony. Thus, new tools with easy operation and high efficiency were still required for genome editing in prokaryotic organisms.
The clustered regularly interspaced short palindromic repeats (CRISPR)-associated systems, which are bacterial adaptive immunity systems against invading DNA from virus, were recently developed as an efficient genome engineering method with wide applications [18] . The CRISPRbased genome editing technology has been widely applied to many organisms, including E. coli [19, 20] , Saccharomyces cerevisiae [21] , Streptomyces spp. [22] , human cells [23] , mouse [24] and zebrafish [25] .
Currently, the most common CRISPR genome editing technology is based on the type II CRISPR-Cas system from Streptococcus pyogenes. This system uses the endonuclease Cas protein 9 (SpCas9) and two RNAs [maturation CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA)] to specify the target of any 20 nt DNA sequence [26] . The target DNA sequence, called protospacer, is however limited by the requirement of a protospacer-adjacent motif NGG, where N represents any nucleotide at the 3¢ end of the target sequence [27] . For genome editing, SpCas9 and the two RNAs (crRNA and tracrRNA) are sufficient to induce dsDNA cleavage at the target site [28] , and it was also found that a single guide RNA (sgRNA) can efficiently replace crRNA and tracrRNA [29] . Thus, in CRISPR-based genome editing, CRISPR-Cas9 induces double-strand DNA break at the target DNA in a programmable manner, and the DNA break is repaired via indel-forming non-homologous end joining or homology-directed repair [19, 30] .
To date, there has been no study reporting on the application of CRISPR genome editing to medically important bacterial strains isolated from patients. Therefore, we performed CRISPR-Cas9-based genome editing in an E. coli SE15 strain isolated from a patient's indwelling urinary catheter. The delivery of CRISPR-Cas9 and donor DNA template, with homology to luxS gene, facilitated highly efficient selection of bacterial colonies that underwent homologous recombination. As a result, we obtained luxS mutant E. coli SE15 clones with a precise 93 base deletion at the target genomic locus. The luxS mutant E. coli SE15 clones showed decreased biofilm formation, and the overall gene expression in the biofilm pathway was repressed. In conclusion, we report the first application of CRISPR-Cas9 to a medically important bacterial strain.
METHODS

Bacteria and culture conditions
In one of our previous studies, E. coli SE15 was isolated from the indwelling catheter of UTI patients in a hospital in South Korea [31] . All strains and plasmids used in this study are listed in Table 1 . E. coli strain DH5a was used for cloning vectors. The strains were routinely cultured at 37 C with shaking at 150 r.p.m. in Luria-Bertani (LB) medium with antimicrobial agents added when necessary. Because pCas vector has temperature-sensitive replication (RepA101ts), pCas electro-transformed E. coli SE15 were cultured at 30 C. The antimicrobial agents used were spectinomycin and kanamycin.
Construction of luxS mutant using CRISPR-Cas9 system Primers used for preparation of the sgRNA and N 20 sequences are listed in Table 2 . Plasmids and genomic DNA were extracted using the NucleoSpin kit (Macherey-Nagel) according to the manufacturer's instructions. In this study, we used two plasmid systems (separate expression of SpCas9 and the sgRNA in pCas and pTargetF, respectively) for genome editing using CRISPR-Cas9 system in E. coli SE15, as described previously [32] . In short, E. coli SE15 luxS mutant strains were constructed by utilizing the three elements: Cas9 constitutive expression plasmid with l-Red recombineering system, pTarterF with target (luxS) sgRNA plasmid and donor template DNA. The donor DNA 
Plasmids pCas repA101(Ts) kan P cas -cas9 P araB -Red lacI q P trc -sgRNA-pMB1 [32] pTargetF pMB1 aadA sgRNA-pMB1 [32] *E. coli SE15 was isolates from indwelling urinary catheter of patients and deposited in Korea Environmental Microorganism Bank (KEMB 9000-004).
contained luxS homologous sequences with 93 bp deletion. The DNA sequence of luxS gene in E. coli SE15 was determined by PCR using luxS primer.
The pTargetF which encodes the sgRNA targeting the luxS gene (target sequence selected by DNA2.0 software) was constructed by site-directed mutagenesis. Briefly, the guide RNA target sequence in pTargetF was mutagenized by PCR to target luxS, and the reaction was treated with DpnI (NEB) to eliminate the wild-type pTargetF. We performed cloning for a pTargetF-luxS spectinomycin-resistant plasmid harbouring a spacer (for guiding Cas9 cleavage of the wild-type SE15) in E. coli DH5a and selected on LB plate with 50 µg ml À1 spectinomycin. The transformants were confirmed by sequencing.
The pCas kanamycin-resistant plasmid was first introduced into E. coli SE15 by electro-transformation. Then, the E. coli SE15 cells harbouring pCas were prepared for co-transformation of the pTargetF-luxS and a donor DNA (Fig. 1) . The co-electro-transformation was performed as previously described [32] . Briefly, cells were mixed with pTargetF, and donor DNA was incubated on ice for 5 min. Co-electrotransformation was conducted in a 2 mm Micro Pulser cuvette (Bio-Rad), and the cells were immediately resuspended with 1 ml pre-warmed LB medium. Cells were then recovered at 30 C for 1 h before being spread onto LB plates supplemented with spectinomycin and kanamycin and incubated overnight at 30 C. The transformants were confirmed by colony PCR and DNA sequencing (Macrogen).
Confirmation of luxS gene deletion in E. coli SE15
To confirm the deletion in luxS sequences and loss of RNA expression in the mutant strain SE15, we performed both reverse transcriptase PCR (RT-PCR) and quantitative realtime PCR (qRT-PCR). Total RNA was isolated from both wild-type E. coli SE15 and DluxS strain SE15 using the NucleoSpin kit (Macherey-Nagel) according to the manufacturer's instructions. Synthesis of cDNA was performed by reverse transcription using Superscript II reverse transcriptase (Invitrogen) with random hexamer primer. Then, 2 µl of the cDNA was used for PCR amplification with luxS primer sets, using 16S rRNA primer sets as internal control gene. Then, the PCR products were separated by DNA electrophoresis [1 % (w/v) agarose gel], and the gel was stained with RedSafe staining kit (iNtRON Biotechnology) and the bands were visualized by UV lamp.
Biofilm formation assay using crystal violet Biofilm formation was measured using the microtitre dish assay system, performed as described previously [33] . Wildtype E. coli SE15 and DluxS SE15 were grown in 96-well plates at 37 C without shaking in TSB (tryptic soy broth) medium supplemented with 0.2 % (w/v) glucose, 1 mM MgSO 4 and 1 mM FeSO 4 . To quantify biofilm formation of E. coli SE15 and DluxS SE15, 150 µl of 0.1% crystal violet solution was added to the wells, and the samples were then washed in distilled water and solubilized in 30 % (v/v) glacial acetic acid. Finally, the absorbance was quantified using a plate reader at 595 nm using 30 % (v/v) glacial acetic acid Verification of luxS related novel genes by qRT-PCR Primers for genes used in this study are listed in Table 2 . Wild-type E. coli SE15 and DluxS SE15 cultures were centrifuged and stored frozen until RNA extraction. Reverse transcription using Superscript II reverse transcriptase (Invitrogen) was performed with random hexamer primer. The cDNA was used as a template for qRT-PCR, which was conducted in a total of 20 µl reaction mixture containing the SYBR Green 2Â mix (Bio-Rad), 0.2 µM target primers and cDNA (1000 ng). The SYBR-Green-labelled PCR products were detected with a CFX96 Touch detection system (Bio-Rad).
Data were gathered during the annealing step, and melting curves were obtained following completion of the reaction.
Raw data were analysed by using the BioCFX Manage (BioRad), and then relative quantitation with the threshold cycle (C t ) method was performed on Microsoft Excel. The comparative threshold method (DDC t analysis) was applied to evaluate the profile in gene expression. Computer programs CFX manager (Bio-Rad) and Excel (Microsoft) were used to calculate: DDC t = DC t , sample ÀDDC t , reference.
RESULTS AND DISCUSSION
Genome editing using CRISPR-Cas9 system for construction of luxS mutant in E. coli SE15 We first sought to delete a large part of luxS gene in E. coli SE15 using CRISPR. The traditional dsDNA-mediated recombineering tool gives relatively low efficiency >10
À4
. Genome editing by small single-strand DNA yields higher mutation rate, but the efficiency reduces significantly with larger replacements and insertions (<2 % for >20 bp) [34] . Since the CRISPR-Cas9 genome editing technique is a powerful tool to construct knockout mutant, we performed CRISPR-assisted genome editing using the two-plasmidbased CRISPR-Cas9 system [32] to mutagenize the luxS gene in E. coli SE15. The two-plasmid system consisted of a pCas kanamycin-resistant plasmid expressing the Cas9 and l-Red recombineering and a pTargetF spectinomycinresistant plasmid carrying the sgRNA with target luxS gene spacer (N 20 ) [32, 35] . The pCas kanamycin-resistant plasmid was firstly inserted into E. coli SE15 by electroporation for constitutive expression of Cas9 protein. Also, we prepared a pTargetF :: luxS spectinomycin-resistant plasmid harbouring a spacer (guiding Cas9 cleavage of the wildtype SE15). Then, the SE15 harbouring pCas was co-transformed with pTargetF :: luxS plasmid and donor DNA, a DNA fragment with sequences homologous to the upstream (100 bp) and downstream (100 bp) regions of the luxS locus and 93 bp deletion (Fig. 1) . We only selected 22 colonies that were spectinomycin and kanamycin resistant and, to check for mutation, conducted PCR with primers targeting luxS ( Table 2) . We resolved the PCR amplicons with electrophoresis and found that the PCR fragments of five mutant candidate colonies (#2, #3, #9, #18 and #20) were smaller (470 bp) than wild-type (563 bp), consistent with 93 bp deletion in luxS (Fig. 1c) . The mutant candidate clones were validated by sequencing, and the results showed that 100 % of five colonies contained the expected 93 bp deletion in luxS gene locus (Fig. 2) , confirming that we obtained luxS deletion efficiency of 22.7 % (5 mutants/22 colonies).
Next, we compared the luxS mRNA expression levels between wild-type SE15 and DluxS SE15 by performing RT-PCR and qRT-PCR (Fig. 3) . qRT-PCR showed that the luxS gene mRNA expression was 2500-fold lower in DluxS SE15 compared to wild-type SE15 (P<0.001). Agarose gel electrophoresis of RT-PCR showed no detectable signal of luxS for DluxS SE15 mutants. These results suggested that the CRISPR-Cas9 system of genome editing is a useful platform not only for a single gene but also for accurate large-scale bacterial genome manipulations.
Effect on the biofilm formation by luxS deletion QS-mechanism-associated genes are essential for biofilm formation, and LuxS/AI-2 is one of the QS mechanisms that is closely associated with biofilm formation in E. coli strains [36, 37] . In the report of Niu, AI-2 was able to control biofilm formation of E. coli via regulating motility [38] . In this study, we investigated whether biofilm formation is influenced by the mutation of luxS in E. coli SE15 strain isolated from the indwelling catheters. No difference in the growth of DluxS mutant and E. coli SE15 was observed, but we found significant changes of biofilm formation between
DluxS mutant and E. coli SE15 (Fig. 4a) . To assess the biofilm formation, we applied crystal violet assay to wild-type SE15 and mutant candidates (#D2, #D3, #D9, #D18 and #D20) grown in 96-well plates (Fig. 4b) . All mutant candidates showed dramatically decreased biofilm formation compared to wild-type SE15 by crystal violet quantification (absorbance at 595 nm): wild-type SE15 (0.798±0.099), D2 (0.445±0.072), D3 (0.203±0.075), D9 (0.174±0.050), D18 (0.216±0.078) and D20 (0.164±0.041). We further assessed the impact of luxS mutation on biofilm formation in a timedependent manner, by comparing a mutant E. coli SE15 (D9) and wild-type. For DluxS SE15, we observed a significantly reduced biofilm formation throughout the time course (0.168±0.021 at 18 h) compared to wild-type (0.742 ±0.042 at 18 h). (Fig. 4c, d ). These results support the hypothesis that AI-2/LuxS-dependent QS is significantly correlated to biofilm formation.
Biofilm-related genes that depend on QS signal are regulated by luxS deletion It has been reported that extracellular AI-2 concentration reaches its peak in mid-late exponential phase and quickly reduces on initiation of stationary phase [8, 39] . The report of Ren et al. [40] demonstrated that several genes, including biofilm-related genes, were repressed in stationary phase of E. coli to adjust to high cell density [40] . Besides, synthesized AI-2 molecules directly stimulate biofilm formation in E. coli by increasing bacterial motility, which is regulated by several factors including MqsR protein [41] . Therefore, we sought to analyse the induction of genes, such as mqsR, pgaBC and csgEF, which are associated with biofilm formation. To this end, we conducted qRT-PCR to quantify the changes in the gene expression levels from low density (3 h) to stationary phase (12 h ) and compared the fold changes between wild-type SE15 and DluxS SE15 (Fig. 5) . We found that, in DluxS SE15, biofilm-formation-associated genes (mqsR, pgaBC and csgEF) were significantly less induced compared to wild-type SE15, while the induction of rpoS, a housekeeping gene, was not affected. The mqsR mRNA expression in DluxS mutant SE15 was induced only 8.8-fold on the initiation of stationary phase compared with 68.3-fold induction in wild-type E. coli SE15. Induction of pgaB and pgaC were 19.7-and 27.9-fold in DluxS mutant compared with 68.3-and 45.9-fold in wild-type. The induction of csgE and csgF gene expression also showed a similar trend: 68.5-and 47.0-fold in DluxS mutant SE15 and 137.6-and 125.5-fold in wild-type. The results showed that CRISPR-mediated knockout of luxS efficiently decreased the biofilm formation of the medically relevant E. coli strain via repression of gene expression in the pathway.
Biofilm formation on the surface of urinary catheters is a key factor in the pathogenesis of CA-UTIs [37] , and the control of biofilm formation by QS mechanism suggested encouraging approaches in treating urogenital infection from E. coli [42] . Here, we sought to develop a novel method to prevent CA-UTI via controlling the biofilm formation on the surface of urinary catheters. In this study, we demonstrated the first application of CRISPR-Cas9 system to construct luxS mutants from the clinical isolate E. coli SE15 found on indwelling urinary catheters of patients. We observed that the bacterial luxS deletion efficiency was 22.7 % and also found that luxS deletion led to reduced biofilm formation and effective downregulation of biofilmrelated genes in wild-type E. coli SE15. Overall, we propose a strategy to use the CRISPR-Cas9 system of genome editing to make a platform for accurate large-scale bacterial genome manipulations. We conclude that the CRISPR-Cas9 system will be useful for investigating the molecular mechanism of how AI-2-dependent QS regulates biofilm formation in clinically important bacteria including and not limited to E. coli SE15.
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